Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT07214532
SIGNAL-ER 101: SIgnatera-Guided initiation of Adjuvant CDK4/6 inhibitor in Intermediate Risk HR+ HER2- Breast Cancer
Status
Open
Conditions
Breast
Phases
2 (Cancer Control)
Age Group
Adult
Main Investiagtor
Avila-Lima, Dayra
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center; Baptist MD Anderson Cancer Center South
Nct ID Number
NCT07214532
Secondary Trial ID Number
25-085-NCP
Keywords
Treatment